ÂÜÀòÂÒÂ×

Robert McIntyre has extensive experience in the venture capital and technology industry. From 2016 to 2018, they were the Co-Founding Partner of Artemis Advisors. In 2013, they served as Vice President of Business Development and Board Member at TeselaGen Biotechnology. From 2018 to 2021, Robert was the Managing Director of LG Technology Ventures, where they were involved in the IPO of Arcellx (NASDAQ: ACLX), SES.ai (NYSE: SES), Amwell (NYSE: AMWL), and the acquisition of Optodot by Meta Materials, Inc. (NASDAQ: MMAT). Robert also invested in H2O.ai in 2020. In 2021, Robert became a Board Member of Element Energy, Inc. and 8i, and a Board Observer of South 8 Technologies. In 2022, they became an Investor of OTI Lumionics.

Robert McIntyre earned a BS in Chemical Engineering from the Massachusetts Institute of Technology in 1998. Robert then went on to The Wharton School and earned an MBA in Finance in 2006.